NPR's Morning Edition examines Global Health Initiative

NPR's Morning Edition examines the Obama administration's Global Health Initiative (GHI) and efforts to combat HIV/AIDS. The $63 billion dollar "initiative preserves the Bush AIDS relief plan," known as PEPFAR, and aims "to allow patients to get care at one location rather than having to seek care at different places. For example, family planning at one facility and HIV care at another," NPR notes. 

The piece includes comments by Anthony Fauci of the National Institute of Allergy and Infectious Diseases and Mark Harrington of the Treatment Action Group, who give their perspectives on the GHI's goals and priorities as well as its effect on HIV funding. 

NPR highlights Uganda, where health officials say "they are already feeling the effects of the [Obama] administration's slow-down in funding for HIV/AIDS. The country was considered an HIV/AIDS model during the Bush administration." The piece includes reaction to such changes by Ugandan doctor Peter Mugyenyi, who runs the country's Joint Clinical Research Center (Wilson, 6/17).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024